<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-molecules-26-01107">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Youdim</surname>
    <given-names>M.B.H.</given-names>
   </name>
   <name>
    <surname>Amit</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Bar-Am</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Weinreb</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Yogev-Falach</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</article-title>
  <source>Neurotox. Res.</source>
  <year>2006</year>
  <volume>10</volume>
  <fpage>181</fpage>
  <lpage>192</lpage>
  <pub-id pub-id-type="doi">10.1007/BF03033355</pub-id>
  <pub-id pub-id-type="pmid">17197368</pub-id>
 </element-citation>
</ref>
